HIND Earnings Date: Nov 13, 2026 (Estimated) — Vyome Holdings, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is HIND's next earnings date?
Vyome Holdings, Inc. (HIND) is expected to report Q3 2026 earnings on Friday, November 13, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.20 on revenue of $24,111.
How did HIND do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), Vyome Holdings, Inc. posted EPS of -$0.09 versus the -$0.19 estimate, a beat of 52.6%. Revenue was $27,027 against a $26,955 estimate. The stock's 1-day post-earnings move was -2.7%.
How much does HIND stock move after earnings?
HIND beat EPS estimates in 4 of its last 8 reported quarters. Over the last 4 reports the stock moved an average of 2.0% (up or down) in the day after earnings.
About Vyome Holdings, Inc.
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | -0.19 | -0.09 | +52.63% | $27,027 | ✅ Beat | -2.70% | +4.50% | -7.21% |
| 2026-05-12 | Q1 2026 | -0.18 | -0.15 | +16.67% | $31,591 | ✅ Beat | -3.03% | +1.52% | +15.15% |
| 2026-03-18 | Q4 2025 | -0.18 | 5.14 | +2955.56% | $36,551 | ✅ Beat | -1.89% | +8.02% | +4.72% |
| 2025-11-14 | Q3 2025 | -0.11 | -3.12 | -2736.36% | $34.6M | ❌ Miss | +0.21% | +2.26% | -16.43% |
| 2022-11-14 | -10.29 | -16.96 | — | $2.8M | ❌ Miss | — | — | — | |
| 2022-08-19 | -0.18 | -297.97 | — | $2.9M | ❌ Miss | — | — | — | |
| 2022-05-23 | -0.17 | -276.16 | — | $2.4M | ❌ Miss | — | — | — | |
| 2022-03-28 | -0.09 | 36.34 | — | $3.1M | ✅ Beat | — | — | — |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $59K total
| Segment | Share | Revenue | YoY | Q2 FY18 | Q3 FY18 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| Product | 85.9% | $50K | — | $634K | $336K | $27K | $148K |
| Royalty | 14.1% | $8K | — | — | — | $8K | $21K |
By region
Q2 FY25 · $1.2M total
| Segment | Share | Revenue | YoY | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 87.9% | $1.1M | -34.3% | — | — | $1.7M | $2.0M |
| Europe | 6.5% | $81K | -59.1% | $201K | $198K | $198K | $168K |
| AUSTRALIA | 5.5% | $68K | -34.0% | — | — | $103K | $111K |
| Non-US | 0.1% | $1K | 0.0% | — | — | $1K | $4K |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.